Disco vs a2z Radiology AI

Side-by-side comparison of AI visibility scores, market position, and capabilities

Disco

EmergingLegal

eDiscovery

Nasdaq LAW; $144.8M revenue 2024 (+5% YoY); 315 large customers; Cecilia AI 32K docs/hour; 90%+ precision vs 75% human; EU launch 2025; legal tech market $31.59B; eDiscovery leader

AI VisibilityBeta
Overall Score
C44
Category Rank
#3 of 3
AI Consensus
61%
Trend
stable
Per Platform
ChatGPT
41
Perplexity
37
Gemini
52

About

DISCO is a legal technology company founded in 2013 in Austin, Texas, on the mission of using AI to make legal work faster, more accessible, and more just. The company's core technology applies machine learning to eDiscovery — the process of identifying, collecting, and producing electronically stored information in litigation — and has extended its AI platform into legal hold, case management, and contract analysis. DISCO is publicly traded on the New York Stock Exchange under the ticker LAW.\n\nThe DISCO platform serves law firms, corporate legal departments, and government agencies. Its AI engine, Cecilia, processes up to 32,000 documents per hour with 90%+ precision, significantly outperforming the roughly 75% accuracy typical of manual human review. This combination of speed and accuracy addresses the core economics of eDiscovery, which historically requires armies of contract attorneys for large-scale document review. DISCO serves 315 large customers and has expanded into the European Union with a 2025 product launch targeting GDPR-compliant eDiscovery workflows.\n\nDISCO reported $144.8 million in revenue for 2024, a 5% year-over-year increase, demonstrating durable growth in a competitive legal tech market. The company's position as one of the few publicly traded legal AI companies provides it with capital market transparency and credibility with enterprise buyers. As litigation volumes grow and legal departments face cost pressure, DISCO's AI-first approach to document review positions it as a structural cost-reduction platform rather than a discretionary software purchase.

Full profile

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.